All In Biotech

Drug Trial Radar · NCT01322490

A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer

Last checked: Nov 19, 2026Latest source record: Sep 4, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,297 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,297

Actual

Start

Nov 28, 2011

Primary completion

Sep 25, 2017

Study completion Dec 15, 2017

Sponsor

Lead sponsor
Bavarian NordicIndustry
Sponsor type
Industry
First posted
Mar 24, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
Male only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether PROSTVAC alone or in combination with GM-CSF is effective in prolonging overall survival in men with few or no symptoms from metastatic, castrate-resistant prostate cancer.

Conditions

  • Prostate Cancer Metastatic

Interventions

  • PROSTVAC-VBiological

  • PROSTVAC-FBiological

  • GM-CSFDrug

  • GM-CSF PlaceboOther

  • PlaceboBiological

    PROSTVAC V/F Placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall SurvivalTime frame: Randomization through the date of death due to any cause. Subjects were followed up for approximately 6 years from the first subject randomized to the completion of the study.

Locations

220 sites in 16 countries. Site status is shown where the registry gives one.

  • Alaska Clinical Research Center, Llc

    Anchorage, Alaska

  • Scottsdale Healthcare

    Scottsdale, Arizona

  • Alta Bates Summit Medical Center

    Berkeley, California

  • Cedars-Sinai Medical Center

    Los Angeles, California

  • Prostate Oncology Specialists, Inc.

    Marina del Rey, California

  • Desert Hematology-Oncology

    Rancho Mirage, California

  • San Bernardino Urological Associates

    San Bernardino, California

  • San Diego Clinical Trials

    San Diego, California

  • Sharp Memorial Hospital

    San Diego, California

  • VA San Diego Healthcare System

    San Diego, California

  • Stanford Advanced Medical Center

    Stanford, California

  • University of Colorado

    Aurora, Colorado

  • The Urology Center of Colorado

    Denver, Colorado

  • Washington Cancer Institute

    Washington D.C., District of Columbia

  • South Florida Medical Research

    Aventura, Florida

  • Manatee Medical Research Institute, LLC

    Bradenton, Florida

  • Florida Urology Physicians

    Fort Myers, Florida

  • Lakeland Regional Cancer Center

    Lakeland, Florida

  • Pinellas Urology, Inc.

    St. Petersburg, Florida

  • James A Haley Veteran Affairs Medical Center

    Tampa, Florida

  • Palm Beach Cancer Institute

    West Palm Beach, Florida

  • North Idaho Urology

    Coeur d'Alene, Idaho

  • Jesse Brown VA

    Chicago, Illinois

  • First Urology PSC

    Jeffersonville, Indiana

  • Northern Indiana Cancer Research Consortium

    South Bend, Indiana

  • The Iowa Clinic, PC Iowa Urology

    West Des Moines, Iowa

  • Tulane University

    New Orleans, Louisiana

  • Ochsner Cancer Institute

    New Orleans, Louisiana

  • Maryland Prostate Center

    Baltimore, Maryland

  • Greater Baltimore Medical Center

    Baltimore, Maryland

  • Union Memorial Hospital

    Baltimore, Maryland

  • Walter Reed Army Medical Center

    Bethesda, Maryland

  • National Cancer Institute - Center for Cancer Research

    Bethesda, Maryland

  • Myron Murdock M.D. LLC

    Greenbelt, Maryland

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts

  • Dana Farber Cancer Institute

    Boston, Massachusetts

  • Mayo Clinic

    Rochester, Minnesota

  • Kansas City VA Medical Center

    Kansas City, Missouri

  • GU Research Network, LLC

    Omaha, Nebraska

  • Nebraska Cancer Specialists

    Omaha, Nebraska

Showing 40 of 220 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.